Inventor · disambiguated record
Youla S. Tsantrizos
Also filed as: TSANTRIZOS YOULA · TSANTRIZOS YOULA S
37 granted patents·5 pending applications·2,078 citations·filing 1989–2019
98Inventor score
Files withBOEHRINGER INGELHEIM CA LTD17BOEHRINGER INGELHEIM INT8GILEAD SCIENCES INC6TSANTRIZOS YOULA S4UNIV MCGILL3
Top patents by PatentIndex Score
42 records- 0199US6608027B1Macrocyclic peptides active against the hepatitis C virusBOEHRINGER INGELHEIM CA LTD·Filed 2001·Granted Aug 19, 2003·449 cites·145 claims
- 0298US6534523B1Hepatitis C inhibitor tri-peptidesBOEHRINGER INGELHEIM CA LTD·Filed 2002·Granted Mar 18, 2003·236 cites·96 claims
- 0398US6420380B2Hepatitis C inhibitor tri-peptidesBOEHRINGER INGELHEIM CA LTD·Filed 2001·Granted Jul 16, 2002·215 cites·51 claims
- 0498US6410531B1Hepatitis C inhibitor tri-peptidesBOEHRINGER INGELHEIM CA LTD·Filed 2001·Granted Jun 25, 2002·220 cites·63 claims
- 0598US6323180B1Hepatitis C inhibitor tri-peptidesBOEHRINGER INGELHEIM CA LTD·Filed 1999·Granted Nov 27, 2001·319 cites·79 claims
- 0697USRE40525EHepatitis C inhibitor tri-peptidesBOEHRINGER INGELHEIM CA LTD·Filed 2005·Granted Sep 30, 2008·40 cites·79 claims
- 0797US6329379B1Hepatitis C inhibitor tri-peptidesBOEHRINGER INGELHEIM CA LTD·Filed 2000·Granted Dec 11, 2001·86 cites·52 claims
- 0896US7141574B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM CA LTD·Filed 2002·Granted Nov 28, 2006·108 cites·62 claims
- 0996US6329417B1Hepatitis C inhibitor tri-pepitidesBOEHRINGER INGELHEIM CA LTD·Filed 2000·Granted Dec 11, 2001·70 cites·55 claims
- 1093US7893084B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM CA LTD·Filed 2008·Granted Feb 22, 2011·23 cites·35 claims
- 1192US6767991B1Hepatitis C inhibitor peptidesBOEHRINGER INGELHEIM CA LTD·Filed 1999·Granted Jul 27, 2004·115 cites·104 claims
- 1291US7241801B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jul 10, 2007·19 cites·33 claims
- 1391US6841566B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM LTD·Filed 2002·Granted Jan 11, 2005·35 cites·62 claims
- 1489US7582770B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Sep 1, 2009·13 cites·23 claims
- 1589US6143715AHepatitis C inhibitor peptide analoguesBOEHRINGER INGELHEIM CA LTD·Filed 1998·Granted Nov 7, 2000·74 cites·33 claims
- 1685US7956068B2Inhibitors of human immunodeficiency virus replicationBOEHRINGER INGELHEIM INT·Filed 2008·Granted Jun 7, 2011·10 cites·13 claims
- 1782US7879851B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2009·Granted Feb 1, 2011·4 cites·15 claims
- 1882US7576079B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM CA LTD·Filed 2006·Granted Aug 18, 2009·4 cites·48 claims
- 1981US7939545B2Inhibitors of human immunodeficiency virus replicationBOEHRINGER INGELHEIM INT·Filed 2007·Granted May 10, 2011·7 cites·30 claims
- 2080US8030309B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2010·Granted Oct 4, 2011·4 cites·15 claims
- 2179US8354429B2Inhibitors of human immunodeficiency virus replicationGILEAD SCIENCES INC·Filed 2008·Granted Jan 15, 2013·3 cites·18 claims
- 2277US8377960B2Inhibitors of human immunodeficiency virus replicationGILEAD SCIENCES INC·Filed 2008·Granted Feb 19, 2013·3 cites·13 claims
- 2375US8841331B2Inhibitors of human immunodeficiency virus replicationGILEAD SCIENCES INC·Filed 2012·Granted Sep 23, 2014·2 cites·3 claims
- 2475US8461180B2Inhibitors of human immunodeficiency virus replicationTSANTRIZOS YOULA S·Filed 2008·Granted Jun 11, 2013·2 cites·5 claims
- 2573US8338441B2Inhibitors of human immunodeficiency virus replicationYOAKIM CHRISTIANE·Filed 2010·Granted Dec 25, 2012·4 cites·12 claims
- 2671US8710230B2Inhibitors of human immunodeficiency virus replicationGILEAD SCIENCES INC·Filed 2012·Granted Apr 29, 2014·1 cites·1 claims
- 2770US8816082B2Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereofTSANTRIZOS YOULA S·Filed 2011·Granted Aug 26, 2014·3 cites·13 claims
- 2869USRE42164EHepatitis C inhibitor tri-peptidesBOEHRINGER INGELHEIM CA LTD·Filed 2008·Granted Feb 22, 2011·0 cites·96 claims
- 2969USRE41356EHepatitis C inhibitor tri-peptidesBOEHRINGER INGELHEIM CA LTD·Filed 2008·Granted May 25, 2010·0 cites·55 claims
- 3068USRE41894EHepatitis C inhibitor tri-peptidesBOEHRINGER INGELHEIM CA LTD·Filed 2008·Granted Oct 26, 2010·0 cites·52 claims
- 3158US2004002448A1Macrocyclic peptides active against the hepatitis C virusBOEHRINGER INGELHEIM CA LTD·Filed 2003·Application pending·0 cites
- 3256US2014296228A1Inhibitors of human immunodeficiency virus replicationGILEAD SCIENCES INC·Filed 2014·Application pending·0 cites
- 3354US7888363B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2007·Granted Feb 15, 2011·0 cites·52 claims
- 3454US2007249629A1Viral Polymerase InhibitorsBEAULIEU PIERRE·Filed 2007·Application pending·0 cites
- 3550US5100456AHerbicidal metabolites of phomopsis convoluvulus for the effective control of field bindweedUNIV MCGILL·Filed 1990·Granted Mar 31, 1992·5 cites·8 claims
- 3647US8076365B2Viral polymerase inhibitorsTSANTRIZOS YOULA S·Filed 2006·Granted Dec 13, 2011·0 cites·23 claims
- 3747US7582766B2Inhibitors of papilloma virusBOEHRINGER INGELHEIM INT·Filed 2004·Granted Sep 1, 2009·0 cites·15 claims
- 3847US5004754ABiofungicidal compositionUNIV LAVAL·Filed 1989·Granted Apr 2, 1991·4 cites·9 claims
- 3947US2013190491A1Inhibitors of human immunodeficiency virus replicationGILEAD SCIENCES INC·Filed 2013·Application pending·0 cites
- 4044US9290526B2Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereofUNIV MCGILL·Filed 2014·Granted Mar 22, 2016·0 cites·20 claims
- 4140US2015307532A1Thienopyrimidine inhibitors of farnesyl and/or geranylgeranyl pyrophosphate synthaseUNIV MCGILL·Filed 2013·Application pending·0 cites
- 4238US11279719B2Substituted bicyclic pyrimidine-based compounds and compositions and uses thereofTSANTRIZOS YOULA S·Filed 2019·Granted Mar 22, 2022·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Youla S. Tsantrizos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →